| Disease Subtype(s) |
HCT Disease Inserts required |
Cellular Therapy Disease Inserts required |
B-lymphoblastic leukemia / lymphoma
- B-lymphoblastic leukemia / lymphoma, NOS (B-cell ALL, NOS) (191)
- B-lymphoblastic leukemia / lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 (192)
- B-lymphoblastic leukemia / lymphoma with t(v;11q23.3); KMT2A rearranged (193)
- B-lymphoblastic leukemia / lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1 (194)
- B-lymphoblastic leukemia / lymphoma with t(12;21) (p13.2;q22.1); ETV6-RUNX1 (195)
- B-lymphoblastic leukemia / lymphoma with t(5;14) (q31.1;q32.3); IL3-IGH (81)
- B-lymphoblastic leukemia / lymphoma with Hyperdiploidy (51-65 chromosomes) (82)
- B-lymphoblastic leukemia / lymphoma with Hypodiploidy (<45 chromosomes) (83)
- B-lymphoblastic leukemia / lymphoma, BCR-ABL1-like (provisional entity) (94)
- B-lymphoblastic leukemia / lymphoma, with iAMP21 (provisional entity) (95)
- T-cell lymphoblastic leukemia / lymphoma (precursor T-cell ALL) (196)
- Early T-cell precursor lymphoblastic leukemia (provisional entity) (96)
- Natural killer (NK)- cell lymphoblastic leukemia / lymphoma (provisional entity) (97)
|
Form 2011 & 2111 |
Form 2011/2011 |
Last modified:
Jul 28, 2021
